Skip to content
Home/Companies/Biotech/ConstructiveBio
ConstructiveBio

ConstructiveBio

Biotech·UK·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns ConstructiveBio?

ConstructiveBio is a British Biotech company, currently owned by Amadeus Capital Partners since 2022.

Hand-verified · updated 2026-05-21

Open JSON · CC-BY
Amadeus Capital Partners
Investor
Amadeus Capital Partners
Amadeus V Technology Fund · 2021 · VC

Key facts

HQUK
SectorBiotech
StatusActive
Websiteconstructive.bio

More from Amadeus V Technology Fund

Other portfolio companies in the same fund.

Pimloc
Active
AI/MLUK· 2025
Safe Intelligence
Active
AI/MLUK· 2025
Sitehop
Active
CybersecurityUK· 2025
Periphery
Periphery
Active
CybersecurityUK· 2024
Refute
Active
AI/MLUK· 2024
Epoch Biodesign
Active
ClimateTechUK· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns ConstructiveBio?

ConstructiveBio is currently owned by Amadeus Capital Partners, through Amadeus V Technology Fund, since 2022.

When did Amadeus Capital Partners acquire ConstructiveBio?

Amadeus Capital Partners acquired ConstructiveBio in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue